Guidances (Drugs) > Bioequivalence Recommendations for Specific Products

MAIN PAGE FDA ►
Guidances (Drugs) > Bioequivalence Recommendations for Specific Products

Section Contents Menu

Guidance, Compliance & Regulatory Information

• Guidances (Drugs)

• Advertising
  
• Bioequivalence Recommendations for Specific Products
• Biopharmaceutics
  
• Biosimilarity
  
• CMC - Microbiology (Chemistry, Manufacturing, and Controls)
  
• Chemistry, Manufacturing, and Controls (CMC)
  
• Clinical / Antimicrobial
  
• Clinical / Medical
  
• Clinical Pharmacology
  
• Combination Products
  
• Concept Papers
  
• Current Good Manufacturing Practices (CGMPs)/Compliance
  
• Drug Safety
  
• Electronic Submissions
  
• FDAAA (Food and Drug Administration Amendments Act)
  
• Generics
  
• Good Review Practices
  
• Industry Letters
  
• International Conference on Harmonisation - Efficacy
  
• International Conference on Harmonisation - Joint Safety/Efficacy (Multidisciplinary)
  
• International Conference on Harmonisation - Quality
  
• International Conference on Harmonisation - Safety
  
• Investigational New Drug Applications
  
• Labeling
  
• Microbiology
  
• Modernization Act
  
• Over-the-Counter
  
• Pharm / Tox
  
• Procedural
  
• Small Entity Compliance Guides
  
• User Fees

-

Bioequivalence Recommendations for Specific Products

• Drug-Related Guidances Main Page¹
  
• Bioequivalence Recommendations for Specific Products (PDF - 81KB) (Issued June 2010)²
  
• Dissolutions Methods Database³

"Please submit comments for any of the guidances posted in the Bioequivalence Recommendations for Specific Products website to the Division of Dockets Management (DDM) under Docket FDA-2007-D-0369-0015. For electronic comments refer to the website http://www.regulations.gov⁴ OR you can mail your written comments to DDM (HFA-305), FDA, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852. Please contact the Regulations.gov HelpDesk at 1-877-378-5457 (toll free) for assistance regarding submissions."